These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 35948563)

  • 1. Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson's disease patients.
    Stern S; Lau S; Manole A; Rosh I; Percia MM; Ben Ezer R; Shokhirev MN; Qiu F; Schafer S; Mansour AA; Mangan KP; Stern T; Ofer P; Stern Y; Diniz Mendes AP; Djamus J; Moore LR; Nayak R; Laufer SH; Aicher A; Rhee A; Wong TL; Nguyen T; Linker SB; Winner B; Freitas BC; Jones E; Sagi I; Bardy C; Brice A; Winkler J; Marchetto MC; Gage FH
    NPJ Parkinsons Dis; 2022 Aug; 8(1):103. PubMed ID: 35948563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinson's disease patients.
    Rosh I; Tripathi U; Hussein Y; Rike WA; Djamus J; Shklyar B; Manole A; Houlden H; Winkler J; Gage FH; Stern S
    NPJ Parkinsons Dis; 2024 Feb; 10(1):38. PubMed ID: 38374278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease in a dish - Using stem cells as a molecular tool.
    Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
    Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Features of Parkinson's Disease in Patient-Derived Midbrain Dopaminergic Neurons.
    Ren Y; Jiang H; Pu J; Li L; Wu J; Yan Y; Zhao G; Guttuso TJ; Zhang B; Feng J
    Mov Disord; 2022 Jan; 37(1):70-79. PubMed ID: 34564901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Parkinson's disease using induced pluripotent stem cells.
    Byers B; Lee HL; Reijo Pera R
    Curr Neurol Neurosci Rep; 2012 Jun; 12(3):237-42. PubMed ID: 22538490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated ECM genes and increased synaptic activity in Parkinson's human DA neurons with PINK1/ PRKN mutations.
    Tripathi U; Rosh I; Ben Ezer R; Nayak R; Hussein Y; Choudhary A; Djamus J; Manole A; Houlden H; Gage FH; Stern S
    NPJ Parkinsons Dis; 2024 May; 10(1):103. PubMed ID: 38762512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells.
    Li H; Jiang H; Zhang B; Feng J
    J Parkinsons Dis; 2018; 8(4):479-493. PubMed ID: 30149462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis.
    Zhou ZD; Saw WT; Ho PGH; Zhang ZW; Zeng L; Chang YY; Sun AXY; Ma DR; Wang HY; Zhou L; Lim KL; Tan EK
    Cell Mol Life Sci; 2022 Nov; 79(12):599. PubMed ID: 36409355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Parkinson's disease with induced pluripotent stem cells harboring α-synuclein mutations.
    Singh Dolt K; Hammachi F; Kunath T
    Brain Pathol; 2017 Jul; 27(4):545-551. PubMed ID: 28585381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.
    Fukusumi H; Togo K; Sumida M; Nakamori M; Obika S; Baba K; Shofuda T; Ito D; Okano H; Mochizuki H; Kanemura Y
    FEBS Open Bio; 2021 Feb; 11(2):354-366. PubMed ID: 33301617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-cell autonomous mechanism of Parkinson's disease pathology caused by G2019S LRRK2 mutation in Ashkenazi Jewish patient: Single cell analysis.
    Kim J; Daadi MM
    Brain Res; 2019 Nov; 1722():146342. PubMed ID: 31330122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic Parkinson's disease patient-derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains.
    Kikuchi T; Morizane A; Doi D; Okita K; Nakagawa M; Yamakado H; Inoue H; Takahashi R; Takahashi J
    J Neurosci Res; 2017 Sep; 95(9):1829-1837. PubMed ID: 28233934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Dysfunction in Dopaminergic Neurons Derived from Patients with LRRK2- and SNCA-Associated Genetic Forms of Parkinson's Disease.
    Vetchinova AS; Kapkaeva MR; Ivanov MV; Kutukova KA; Mudzhiri NM; Frumkina LE; Brydun AV; Sukhorukov VS; Illarioshkin SN
    Curr Issues Mol Biol; 2023 Oct; 45(10):8395-8411. PubMed ID: 37886972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
    Beevers JE; Caffrey TM; Wade-Martins R
    Biochem Soc Trans; 2013 Dec; 41(6):1503-8. PubMed ID: 24256244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson's Disease?
    O'Hara DM; Pawar G; Kalia SK; Kalia LV
    Front Neurosci; 2020; 14():577. PubMed ID: 32625052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells.
    Son MY; Sim H; Son YS; Jung KB; Lee MO; Oh JH; Chung SK; Jung CR; Kim J
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):584-603. PubMed ID: 28235153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathway-specific dysregulation of striatal excitatory synapses by LRRK2 mutations.
    Chen C; Soto G; Dumrongprechachan V; Bannon N; Kang S; Kozorovitskiy Y; Parisiadou L
    Elife; 2020 Oct; 9():. PubMed ID: 33006315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iPS cells in the study of PD molecular pathogenesis.
    Cobb MM; Ravisankar A; Skibinski G; Finkbeiner S
    Cell Tissue Res; 2018 Jul; 373(1):61-77. PubMed ID: 29234887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.
    Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J
    Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of monogenic genes in idiopathic Parkinson's disease.
    Reed X; Bandrés-Ciga S; Blauwendraat C; Cookson MR
    Neurobiol Dis; 2019 Apr; 124():230-239. PubMed ID: 30448284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.